Articles by Disease (Chronic Peptic Ulcer)

Efficacy of the Newest COX-2 Selective Inhibitors in Rheumatic Disease

Journal: Current Pharmaceutical Design
Volume: 13
Page: 2228-2236
Author(s): Herbert S.B. Baraf

Global Gastrointestinal Safety Profile of Etoricoxib and Lumiracoxib

Journal: Current Pharmaceutical Design
Volume: 13
Page: 2237-2247
Author(s): Yuhong Yuan and Richard H. Hunt

How to Advise Aspirin Use in Patients Who Need NSAIDs

Journal: Current Pharmaceutical Design
Volume: 13
Page: 2248-2260
Author(s): F. Sopena and A. Lanas

Radionuclide Liver Cancer Therapies: From Concept to Current Clinical Status

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7
Page: 441-459
Author(s): Maarten A.D. Vente, Monique G.G. Hobbelink, Alfred D. van het Schip, Bernard A. Zonnenberg and Johannes F.W. Nijsen

Platelets and Vascular Risk: An Option for Treatment

Journal: Current Pharmaceutical Design
Volume: 13
Page: 1669-1683
Author(s): I. A. Jagroop, A. I. Kakafika and D. P. Mikhailidis

Strategies for Design of Non Peptide CCK1R Agonist/Antagonist Ligands

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 1180-1194
Author(s): M. Teresa Garcia-Lopez, Rosario Gonzalez-Muniz, Mercedes Martin-Martinez and Rosario Herranz

Role of CCK/Gastrin Receptors in Gastrointestinal/Metabolic Diseases and Results of Human Studies Using Gastrin/CCK Receptor Agonists/Antagonists in these Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 7
Page: 1211-1231
Author(s): Marc J. Berna and Robert T. Jensen